|
Basic Characteristics of Mutations
|
|
Mutation Site
|
A483C |
|
Mutation Site Sentence
|
Table 1 |
|
Mutation Level
|
Nucleotide level |
|
Mutation Type
|
|
|
Gene/Protein/Region
|
LMP-1 |
|
Standardized Encoding Gene
|
LMP-1
|
|
Genotype/Subtype
|
- |
|
Viral Reference
|
-
|
|
Functional Impact and Mechanisms
|
|
Disease
|
Lymphoma, Extranodal NK-T-Cell
|
|
Immune
|
- |
|
Target Gene
|
-
|
|
Clinical and Epidemiological Correlations
|
|
Clinical Information
|
Y |
|
Treatment
|
- |
|
Location
|
France |
|
Literature Information
|
|
PMID
|
27061907
|
|
Title
|
Clonal deleted latent membrane protein 1 variants of Epstein-Barr virus are predominant in European extranodal NK/T lymphomas and disappear during successful treatment
|
|
Author
|
Halabi MA,Jaccard A,Moulinas R,Bahri R,Al Mouhammad H,Mammari N,Feuillard J,Ranger-Rogez S
|
|
Journal
|
International journal of cancer
|
|
Journal Info
|
2016 Aug 15;139(4):793-802
|
|
Abstract
|
Extranodal natural killer/T-cell lymphomas (NK/TL), rare in Europe, are Epstein-Barr virus (EBV) associated lymphomas with poor outcomes. Here, we determined the virus type and analyzed the EBV latent membrane protein-1 (LMP1) gene sequence in NK/TL from French patients. Six clones of viral LMP1 were sequenced by Sanger technology in blood from 13 patients before treatment with an l-asparaginase based regimen and, for 8 of them, throughout the treatment. Blood LMP1 sequences from 21 patients without any known malignancy were tested as controls. EBV Type A was identified for 11/13 patients and for all controls. Before treatment, a clonal LMP1 gene containing a 30 bp deletion (del30) was found in 46.1% of NK/TL and only in 4.8% of controls. Treatment was less effective in these patients who died more rapidly than the others. Patients with a deleted strain evolving toward a wild-type strain during treatment reached complete remission. The LMP1 gene was sequenced by highly sensitive next-generation sequencing technology in five NK/TL nasopharyngeal biopsies, two of them originating from the previous patients. Del30 was present in 100% of the biopsies; two viruses at least coexisted in three biopsies. These results suggest that del30 may be associated with poor prognosis NK/TL and that strain evolution could be used as a potential marker to monitor treatment.
|
|
Sequence Data
|
-
|